Consumers Are Looking Beyond the Brand Authorized, or branded, GLP-1 medicines are generally associated with...
GLP-1s Blogs
Great strategies start with understanding People. Explore our GLP-1s blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news.
GLP-1 Discontinuation: What Online Consumer Conversations Reveal About Long-Term Obesity Management
GLP-1 Discontinuation: Consumers Are Changing Conversation Healthcare has entered a new era where consumers are no...
From Dose Adjustments to Emotional Responses: What Consumers Are Saying About GLP-1 Weight Loss Plateaus
The Emergence of Informed Consumerization People begin their treatment journey as Patients, but their online behavior...
The Rise of the Metabolic Healthcare Consumer
From Weight Loss to Liver Health: What Consumer Conversations Reveal About the Emerging MASH Landscape Conversations...
Understanding GLP-1 Therapies: FDA-Approved Treatments, Compounded Medications, and Nutritional Support
GLP-1 Therapies: Targeting Metabolic Disease GLP-1 receptor agonists are prescription medicines designed to mimic...
Beyond the Clinical Data: Why Patient, Consumer and HCP Conversations Matter in the Future of GLP-1s and Cancer Care
The Conversation Has Already Started Scientific conferences often spark new healthcare discussions, where healthcare...
GLP-1s Are Breaking Into New Territory: What ASCO 2026 Reveals About Their Potential in Oncology
A New Frontier for GLP-1 Therapies Few therapeutic classes have generated as much attention as GLP-1 therapies in...
GLP-1s Are Redefining More Than Healthcare – They are Reshaping Entire Industries
Healthcare Innovation with Wide Market Effects GLP-1 receptor agonists, initially developed for type 2 diabetes and...
Motivation and Behavior: The Influence of GLP-1 Therapies Beyond Metabolic Health
GLP-1: More Than a Metabolic Hormone Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly becoming one...
The GLP-1 Narrative is Splitting: Convenience vs Coverage
The GLP-1 Inflection Point Coming out of industry news this past week are two developments that, on the surface, look...
Talking Medicines and Socialgist Partner to Capture the GLP-1 Consumer Voice from Real-Life Conversations
The GLP-1 consumer shift is clear, but the signals behind it are often hard to see. That’s why we’ve partnered with...
GLP-1s and the Information Explosion: When Consumer Curiosity Meets AI-Driven Health Decisions
The Rise of the Health-Seeking Consumer We are witnessing a fundamental shift: Patients are no longer simply passive...